Trial intelligence / Profile preview

Aripiprazole for Methamphetamine Dependence

NCT00497055Phase 2Completed

Sponsor
San Francisco Department of Public Health
Start
Mar 2009
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of aripiprazole in methamphetamine use disorder (MUD), sponsored by San Francisco Department of Public Health. Started Mar 2009; status: completed.

02

Drugs

aripiprazole
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT00497055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00497055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call